MDT

87.11

-0.93%↓

A

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

MDT

87.11

-0.93%↓

A

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

MDT

87.11

-0.93%↓

A

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

MDT

87.11

-0.93%↓

A

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

MDT

87.11

-0.93%↓

A

115.09

-0.3%↓

VEEV

151.46

-3.57%↓

HQY

78.12

-6.83%↓

TLRY

6.58

-1.94%↓

Search

Smith & Nephew PLC ADR

Gesloten

33.49 1.24

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

33.11

Max

33.89

Belangrijke statistieken

By Trading Economics

Inkomsten

35M

331M

Verkoop

203M

3.2B

K/W

Sectorgemiddelde

22.818

66.418

Dividendrendement

2.43

Winstmarge

10.368

Werknemers

16,988

EBITDA

133M

856M

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

+5.52% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

2.43%

2.36%

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-1.3B

14B

Vorige openingsprijs

32.25

Vorige sluitingsprijs

33.49

Technische score

By Trading Central

Vertrouwen

Bullish Evidence

Smith & Nephew PLC ADR Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

10 apr 2026, 17:04 UTC

Belangrijke Marktbewegers

FDA Rejects Replimune's Melanoma Drug for a Second Time

11 apr 2026, 00:00 UTC

Winsten
Acquisities, Fusies, Overnames

Big Yachts, Big Bucks -- Barrons.com

10 apr 2026, 21:55 UTC

Acquisities, Fusies, Overnames

Paramount Warrants Are an Underappreciated Aspect of Warner Bros. Deal -- Barrons.com

10 apr 2026, 21:01 UTC

Winsten

Cango Inc.: Files Annual Report on Form 20-F With SEC

10 apr 2026, 20:50 UTC

Marktinformatie

Energy & Utilities Roundup: Market Talk

10 apr 2026, 20:50 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Basic Materials Roundup: Market Talk

10 apr 2026, 20:50 UTC

Marktinformatie

Health Care Roundup: Market Talk

10 apr 2026, 20:31 UTC

Marktinformatie

Convenience Store Traffic Slows as Gas Prices Rise -- Market Talk

10 apr 2026, 20:10 UTC

Acquisities, Fusies, Overnames

This Women's Health Company Is Drawing Takeover Interest. The Stock Is Soaring. -- Barrons.com

10 apr 2026, 19:15 UTC

Marktinformatie

Global Energy Roundup: Market Talk

10 apr 2026, 19:15 UTC

Marktinformatie

Oil Futures Settle Lower With Focus on U.S.-Iran Talks -- Market Talk

10 apr 2026, 19:08 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

10 apr 2026, 19:08 UTC

Marktinformatie

U.S. Natural Gas Futures End Week Lower -- Market Talk

10 apr 2026, 18:38 UTC

Marktinformatie

Canada's Job Market Showing Soft Demand, Structural Decline in Supply -- Market Talk

10 apr 2026, 18:25 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Precious Metals Finish With Weekly Gains -- Market Talk

10 apr 2026, 18:05 UTC

Marktinformatie

Rising Commodity Prices Seen Carrying More Weight Than Jobs Data for Bank of Canada Watchers -- Market Talk

10 apr 2026, 17:31 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

U.S. Oil Rig Count Unchanged This Week At 411 -- Market Talk

10 apr 2026, 17:26 UTC

Winsten

Big Banks' Profits Set to Rise Even as 'Wall of Worry' Looms -- Barrons.com

10 apr 2026, 17:10 UTC

Marktinformatie

White House Defense of Stablecoin Yields Is Welcome Move, Grayscale Says -- Market Talk

10 apr 2026, 17:00 UTC

Belangrijke Nieuwsgebeurtenissen

Construction Business Taking a Hit From Iran Conflict -- WSJ

10 apr 2026, 16:20 UTC

Marktinformatie

Health Care Roundup: Market Talk

10 apr 2026, 16:15 UTC

Marktinformatie

Global Commodities Roundup: Market Talk

10 apr 2026, 16:12 UTC

Winsten

Partners Group CEO: Group Well Positioned to Navigate Current Complex Environment

10 apr 2026, 16:11 UTC

Winsten

Partners Group: Traditional Programs Contributed $3.3B

10 apr 2026, 16:10 UTC

Winsten

Partners Group: $5B of New Commitments Came From Bespoke Solutions

10 apr 2026, 16:10 UTC

Winsten

Partners Group: That Is Across All Private Markets Asset Classes and Client Strategies

10 apr 2026, 16:10 UTC

Winsten

Partners Group 1Q New Client Demand $8.3B

10 apr 2026, 16:09 UTC

Winsten

Partners Group Continued to See Positive Fundraising Momentum in 1Q

10 apr 2026, 15:54 UTC

Acquisities, Fusies, Overnames

Plenitude Completes Acquisition of Acea Energia

10 apr 2026, 15:38 UTC

Marktinformatie

Global Energy Roundup: Market Talk

Peer Vergelijking

Prijswijziging

Smith & Nephew PLC ADR Prognose

Koersdoel

By TipRanks

5.52% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 34.96 USD  5.52%

Hoogste 35 USD

Laagste 34.91 USD

Gebaseerd op 2 Wall Street-analisten die 12-maands prijsdoelen bieden voor Smith & Nephew PLC ADR - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

2 ratings

0

Buy

2

Hold

0

Sell

Technische score

By Trading Central

26.64 / 28.37Steun & Weerstand

Korte Termijn

Bullish Evidence

Gemiddeld Termijn

Bullish Evidence

Lange Termijn

Bullish Evidence

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Smith & Nephew PLC ADR

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
help-icon Live chat